InsideTumorCells: Cancer therapy with reduced systemic exposure and release of the drug into tumour cells (Q2866735)
Jump to navigation
Jump to search
Project Q2866735 in Portugal
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | InsideTumorCells: Cancer therapy with reduced systemic exposure and release of the drug into tumour cells |
Project Q2866735 in Portugal |
Statements
42,500.0 Euro
0 references
50,000.0 Euro
0 references
85.0 percent
0 references
18 June 2019
0 references
15 February 2022
0 references
UNIVERSIDADE DE COIMBRA
0 references
Q2988597 (Deleted Item)
0 references
40°12'40.28"N, 8°25'46.06"W
0 references
InsideTumorCells pretende proteger por patente os direitos de PI de um novo medicamento para o cancro que liberta o fármaco dentro das células tumorais, minimizando os efeitos secundários. (Portuguese)
0 references
InsideTumorCells intends to patently protect the IP rights of a new cancer medicine that releases the drug into tumour cells, minimising side effects. (English)
7 July 2021
0 references
InsideTumorCells vise à protéger de manière patente les droits de propriété intellectuelle d’un nouveau médicament contre le cancer qui libère le médicament dans les cellules tumorales, ce qui réduit au minimum les effets secondaires. (French)
4 December 2021
0 references
InsideTumorCells zielt darauf ab, die Rechte des geistigen Eigentums eines neuen Krebsarzneimittels, das das Medikament in Tumorzellen freisetzt, patentrechtlich zu schützen und so Nebenwirkungen zu minimieren. (German)
13 December 2021
0 references
InsideTumorCells streeft ernaar om de IP-rechten van een nieuw geneesmiddel tegen kanker dat het geneesmiddel vrijgeeft in tumorcellen te beschermen en bijwerkingen te minimaliseren. (Dutch)
18 December 2021
0 references
InsideTumorCells mira a proteggere in modo breve i diritti di proprietà intellettuale di un nuovo medicinale antitumorale che rilascia il farmaco nelle cellule tumorali, riducendo al minimo gli effetti collaterali. (Italian)
17 January 2022
0 references
InsideTumorCells tiene como objetivo proteger de forma patente los derechos de propiedad intelectual de un nuevo medicamento contra el cáncer que libera el medicamento a las células tumorales, minimizando los efectos secundarios. (Spanish)
20 January 2022
0 references
Coimbra
0 references
Identifiers
CENTRO-01-0145-FEDER-042773
0 references